Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-25 @ 3:44 AM
NCT ID:
NCT00334802
Eligibility Criteria:
Inclusion Criteria:
* Histologically and/or cytologically confirmed breast cancer
* Received adjuvant/neo-adjuvant chemotherapy for breast cancer with anthracycline regimen
* To have at least one measurable region
* Eastern Cooperative Oncology Group (ECOG) Performance Status: 0-1
* To have adequate organ function (bone marrow, liver and renal function)
Exclusion Criteria:
* To have interstitial pneumonia or pulmonary fibrosis
* To have inflammatory breast cancer
* Within 28 days after the latest chemotherapy or radiotherapy, 14 days after the latest hormonal/immunotherapy or 7 days after surgery
* To have brain metastases with symptoms
* To have severe complication (cardiac infarction, infection, drug hypersensitivity or diabetes)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
74 Years
Study:
NCT00334802
Study Brief:
Protocol Section:
NCT00334802